Unicycive Therapeutics (UNCY) PT Raised to $21 at Benchmark to Reflect Reverse Split
Tweet Send to a Friend
(Updated - September 15, 2025 8:57 AM EDT)
Benchmark analyst Bruce Jackson raised the price target on Unicycive Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Benchmark analyst Bruce Jackson raised the price target on Unicycive Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
